Aet Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AET PHARMA, and what generic and branded alternatives to AET PHARMA drugs are available?
AET PHARMA has two approved drugs.
Summary for Aet Pharma
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Aet Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aet Pharma | LEFLUNOMIDE | leflunomide | TABLET;ORAL | 213497-001 | May 10, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aet Pharma | LEFLUNOMIDE | leflunomide | TABLET;ORAL | 213497-002 | May 10, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aet Pharma | POSACONAZOLE | posaconazole | TABLET, DELAYED RELEASE;ORAL | 213454-001 | Feb 1, 2021 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
